Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro.

Source:http://linkedlifedata.com/resource/pubmed/id/15827327

Download in:

View as

General Info

PMID
15827327